Related Experiment Videos
Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation
J P Donohue1, R S Foster, R G Rowland
1Department of Urology, Indiana University School of Medicine, Indianapolis.
The Journal of Urology
|August 1, 1990
Summary
Nerve-sparing retroperitoneal lymphadenectomy preserves ejaculatory function in all patients. This technique is feasible for selected cases, maintaining acceptable cancer relapse and survival rates.
Area of Science:
- Urology
- Surgical Oncology
- Reproductive Medicine
Background:
- Retroperitoneal lymphadenectomy (RPLND) is a standard treatment for testicular cancer.
- Traditional RPLND can impair sympathetic nerve function, leading to ejaculatory dysfunction.
- Preserving postganglionic sympathetic nerve fibers is crucial for maintaining sexual function.
Purpose of the Study:
- To investigate the feasibility and oncological outcomes of nerve-sparing retroperitoneal lymphadenectomy (nsRPLND).
- To assess the impact of nsRPLND on preserving ejaculatory function.
- To evaluate oncological control in patients undergoing nsRPLND.
Main Methods:
- A cohort of 75 patients underwent nsRPLND between 1978 and the study period.
- Patient selection was based on clinical stage, primarily clinical stage I.
- No adjuvant chemotherapy was administered post-surgery.
Main Results:
- All 75 patients preserved ejaculatory function postoperatively.
- No local recurrences were observed in 61 patients with pathologically negative nodes.
- Four patients with pathological stage II disease experienced relapse but achieved disease-free status after salvage treatment.
Conclusions:
- Nerve-sparing retroperitoneal lymphadenectomy is a feasible and effective surgical technique.
- This approach reliably preserves ejaculatory function.
- nsRPLND can be safely applied to selected patients, including those with low-volume positive nodes, without compromising oncological outcomes.